Patient recruitment firm Trialbee joins forces with TriNetX

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Who_I_am)
(Image: Getty/Who_I_am)

Related tags: TriNetX, Trialbee, Patient recruitment

Trialbee and TriNetX are teaming up to accelerate research and develop new services with the goal of improving patient access to clinical trials as a care option.

A technology provider in the clinical trial patient matching and engagement space, Trialbee has announced a partnership with the global health network, TriNetX.

Trialbee CEO Lollo Eriksson described the partnership as a “great opportunity to leverage both organizations' capabilities to develop new services in order to optimize clinical trials to empower patients with clinical trials as a care option.”

“This partnership will significantly widen Trialbee’s service offerings to drive patient recruitment and retention,”​ Eriksson said in a statement.

According to the companies, the partnership also will involve work to develop new services aimed at accelerating clinical trials.

“Our collaboration with Trialbee further enhances our health care organizations’ capabilities to streamline patient identification and recruitment. We see this partnership as a complementary effort to our digital developments around protocol design, site identification, and access to patients,”​ said Maulik Mehta, senior vice president of corporate development at TriNetX.

Based in Cambridge, MA, TriNetX has partnered with health care organizations across 23 countries and thousands of sites, and recently was named as a technology partner in two coordinating centers of the US Food and Drug Administration’s (FDA) Sentinel System.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars